FMA
NTRP

FNY Managed Accounts’s Neurotrope, Inc. Common NTRP Stock Holding History

FNY Managed Accounts’s Portfolio NTRP Stock Details NTRP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-1,100
Closed -$20K – 731
2017
Q1 		$20K Buy
+1,100
New +$20.8K 0.06% 356

Other funds holding NTRP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
OCMI
Oaktop Capital Management II Chatham, New Jersey $1.34B AUM 114.5% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
TCM
Tanaka Capital Management New York $59.9M AUM
Eagle Capital Management (New York)
Eagle Capital Management (New York) New York $29.8B AUM 12.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PFO
Pathstone Family Office Englewood, New Jersey $13.1B AUM 21.02% 1-Year Est. Return
JMPWA
JP Morgan Private Wealth Advisors San Francisco, California $35B AUM 24.26% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

FNY Managed Accounts's NTRP Position: Q2 2017 in Review

FNY Managed Accounts sold out of Neurotrope, Inc. Common (NTRP) in Q2 2017, closing a stake of 1,100 shares — an estimated $20K sold.

FNY Managed Accounts first reported a position in NTRP in Q1 2017 and held it in 1 quarter. The position peaked at $20K in Q1 2017. 27 funds tracked by Wall St. Rank hold NTRP as of Q2 2017.

  • FNY Managed Accounts reported no remaining Neurotrope, Inc. Common position as of Q2 2017 after selling out during the quarter.
  • FNY Managed Accounts sold 1,100 Neurotrope, Inc. Common shares in Q2 2017, an estimated $20K.
  • FNY Managed Accounts first reported a position in Neurotrope, Inc. Common in Q1 2017 and held it in 1 quarter.
  • FNY Managed Accounts's Neurotrope, Inc. Common position peaked at $20K in Q1 2017.
  • 27 funds tracked by Wall St. Rank held Neurotrope, Inc. Common as of Q2 2017.

Based on FNY Managed Accounts's 13F filing for Q2 2017, filed 10 Aug 2017.